Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 5
2015 3
2017 4
2018 2
2019 1
2020 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment.
Lamure S, Paul F, Gagez AL, Delage J, Vincent L, Fegueux N, Sirvent A, Gehlkopf E, Veyrune JL, Yang LZ, Kanouni T, Cacheux V, Moreaux J, Bonafoux B, Cartron G, De Vos J, Ceballos P. Lamure S, et al. Among authors: gagez al. J Clin Med. 2020 Jul 12;9(7):2204. doi: 10.3390/jcm9072204. J Clin Med. 2020. PMID: 32664688 Free PMC article.
Pediatric Palliative Care for a French Hospital-At-Home Facility: A Case Report.
Rubenstrunk A, Gagez AL, Hoeusler CH, Demol E, Mahieux I, Lavedrine F, Raff F, Vuylsteke J, Mazure J, Lecouffe R. Rubenstrunk A, et al. Among authors: gagez al. J Pediatr Health Care. 2024 Jan-Feb;38(1):90-96. doi: 10.1016/j.pedhc.2023.07.005. Epub 2023 Sep 14. J Pediatr Health Care. 2024. PMID: 37676183 No abstract available.
Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study.
Gagez AL, Paul F, Alaterre E, Gouilleux-Gruart V, Tuaillon E, Lepretre S, Ternant D, Letestu R, Moreaux J, Cartron G. Gagez AL, et al. Leuk Lymphoma. 2021 Dec;62(13):3160-3169. doi: 10.1080/10428194.2021.1955879. Epub 2021 Nov 22. Leuk Lymphoma. 2021. PMID: 34806520
Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study.
Cartron G, Letestu R, Dartigeas C, Tout M, Mahé B, Gagez AL, Ferrant E, Guiu B, Villemagne B, Letuan P, Aurran T, Orsini-Piocelle F, Banos A, Feugier P, Leblond V, de Guibert S, Tournilhac O, Dupuis J, Delmer A, Rouillé V, Ternant D, Leprêtre S. Cartron G, et al. Among authors: gagez al. Haematologica. 2018 Aug;103(8):e356-e359. doi: 10.3324/haematol.2017.182352. Epub 2018 Mar 8. Haematologica. 2018. PMID: 29519866 Free PMC article. Clinical Trial. No abstract available.
18 results